Regulation of growth of cultured smooth muscle cells from diabetic rats by interleukin-1β: Role of nitric oxide

European Journal of Pharmacology

Volumn 311, Issue 1, 1996, Pages 79-86

  Etienne, Pascale ^a   Parés Herbuté, Nuria ^a   Monnier, Louis ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Diabetes; Growth; Interleukin 1 ; Nitric oxide (NO); Smooth muscle cell, vascular

Indexed keywords

CYCLIC GMP; INTERLEUKIN 1BETA; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; STREPTOZOCIN DIABETES;

EID: 0030571004     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00398-6     Document Type: Article

References (43)

1. Alipui, C., K. Ramosk and T.E. Tenner, 1993, Alterations of rabbit aortic smooth muscle cell proliferation in diabetes mellitus, Cardiovasc. Res. 27 (7), 1229.
2. Archer, S., 1993, Measurement of nitric oxide in biological models, FASEB J. 7, 349.
3. Beasley, D., J.H. Schwartz and B.M. Brenner, 1991, Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells, J. Clin. Invest. 87, 602.
4. Bodin, P., S. Richard, C. Travo, P. Berta, J.C. Stoclet, S. Papin and P. Travo, 1991, Responses of subcultured rat aortic smooth myocytes to vasoactive agents and KC1-induced depolarization, Am. J. Physiol. 260, C151.
5. Bonin, P.D., G.J. Fici and J.P. Singh, 1989, Interleukin-1 promotes proliferation of VSMC in coordination with PDGF or a monocyte-derived factor, Exp. Cell Res. 181, 475.
6. Busse, R. and A. Mulsch, 1990, Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells, FEBS Lett. 275, 87.
7. Corbett, J.A., R.G. Tilton, K. Chang, K.S. Hasan, Y. Ido, J.L. Wang, M.A. Sweetland, J.R. Lancaster, J.R. Williamson and M.L. Mc Daniel, 1992, Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction, Diabetes 41, 552.
8. Cornwell, T.L., E. Arnold, N.J. Boerth and T.M. Lincoln, 1994, Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. 267, C1405.
9. Dinarello, C.A., 1985, An update on human interleukin-1: from molecular biology to clinical relevance, J. Clin. Immunol. 5, 287.
10. Ellman, C., J.A. Corbett, T.P. Misko, M. Mc Daniel and K.P. Beckerman, 1993, Nitric oxide mediates interleukin-1-induced cellular cytotoxicity in the rat ovary. A potential role for nitric oxide in the ovulatory process, J. Clin. Invest. 92, 3053.
11. Etienne, P., N. Parés-Herbuté and L. Monnier, 1996, Enhanced antiproliferative effect of nitric oxide in cultured smooth muscle cells from diabetic rats, J. Cardiovasc. Pharmacol. 27, 140.
12. Fukuo, K., T. Inoue, S. Morimoto, T. Nakahashi, O. Yasuda and S. Kitano, 1995, Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells, J. Clin. Invest. 95, 669.
13. Garg, U.C. and A. Hassid, 1989, Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells, J. Clin. Invest. 83, 1774.
14. Gay, C.G. and J.A. Winkles, 1991, Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells, Proc. Natl. Acad. Sci. USA 88, 296.
15. Hansson, G.K., L. Jonasson, P.S. Seifert and S. Stemme, 1989, Immune mechanism in atherosclerosis, Arteriosclerosis 9, 567.
16. Ignarro, L.J., J.M. Fukuto, J.M. Griscavage, N.E. Rogers and R.E. Byrns, 1993, Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine, Proc. Natl. Acad. Sci. USA 90, 8103.
17. Ikeda, U., K. Furuhashi, T. Kanbe and K. Shimada, 1995, Ouabain enhances nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1β, Eur. J. Pharmacol. 288, 379.
18. 2 production by vascular smooth muscle cells, Biochem. Biophys. Res. Commun. 194 (1), 420.
19. Kannel, W.B. and D.L. Mc Gee, 1978, Diabetes and cardiovascular disease: the Framingham study. JAMA 241, 2035.
20. Kanno, K., Y. Hirata, T. Imai and F. Marumo, 1993, Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells, Hypertension 22, 34.
21. Kawano, M., T. Koshikawa, T. Kanzaki, N. Morisaki, Y. Saito and S. Yoshida, 1993, Diabetes mellitus induces accelerated growth of aortic smooth muscle cells: association with overexpression of PDGFβ-receptors, Eur. J. Clin. Inv. 23, 84.
22. Klagsbrun, M. and E. Edelman, 1989, Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis, Arteriosclerosis 9, 269.
23. Knowles, R.G. and S. Moncada, 1994, Nitric oxide synthases in mammals, Biochem. J. 298, 249.
24. Libby, P., 1990, Inflammatory and immune mechanisms in atherogenesis, Atheroscl. Rev. 21, 79.
25. Libby, P., D.J. Wyler, M.W. Jamcka and C.A. Dinarello, 1985, Differential effects of human interleukin-1 on growth of human fibroblasts and vascular smooth muscle cells, Arteriosclerosis 5, 186.
26. Libby, P., S.J.C. Warner and G.B. Friedman, 1988, Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids, J. Clin. Invest. 81, 487.
27. Majack, R.A., M.W. Majesky and L.V. Goodman, 1990, Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β, J. Cell. Biol. 111, 239.
28. Marietta, M.A., 1993, Nitric oxide synthase structure and mechanism, J. Biol. Chem. 268 (17), 12231.
29. Moncada, S., R.M.J. Palmer and E.A. Higgs, 1991, Nitric oxide: physiology, pathophysiology and pharmacology, Pharmacol. Rev. 43, 109.
30. Moyer, C.F., D. Sajuthi, H. Tulli and J.K. Williams, 1991, Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis, Am. J. Pathol. 138, 951.
31. Murad, F., C.K. Mittal, W.P. Arnold, S. Katsuki and H. Kimura, 1978, Guanylate cyclase: activation by azide, nitro compounds, and hydroxyl radical and inhibition by hemoglobin and myoglobin, Adv. Cycl. Nucl. Res. 9, 145.
32. Nathan, C., 1992, Nitric oxide as a secretory product of mammalian cells, FASEB J. 6, 3051.
33. Nunokawa, Y., N. Ishida and S. Tanaka, 1993, Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells, Biochem. Biophys. Res. Commun. 191, 89.
34. Pinsky, D.J., B. Cai, X. Yang, C. Rodriguez, R.R. Sciacca and P.J. Cannon, 1995, The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor β, J. Clin. Invest. 6, 677.
35. Raines, E.W., S.K. Dower and R. Ross, 1989, Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA, Science 243, 393.
36. Rangnekar, V., S. Waheed, T.J. Davies, F.G. Toback and V.M. Rangnekar, 1991, Antimitogenic and mitogenic actions of interleukin-1 in diverse cell types are associated with induction of gro gene expression, J. Biol. Chem. 266, 2415.
37. Ross, R., 1986, The pathogenesis of atherosclerosis: an update, New Engl. J. Med. 314, 488.
38. Ross, R., 1993, The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature London 362, 801.
39. Ruderman, N.B. and C. Handenschild, 1984, Diabetes as an atherogenic factor, Prog. Cardiovasc. Dis. 26, 373.
40. Salvemini, D., T.P. Misko, J.L. Masferren, K. Seibert, M.G. Currie and P. Needleman, 1993, Nitric oxide activates cyclooxygenase enzymes, Proc. Natl. Acad. Sci. USA 90, 7240.
41. Schini, V.B., D.C. Junquero, T. Scott-Burden and P.M. Vanhoutte, 1991, Interleukin-1β induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta, Biochem. Biophys. Res. Commun. 176 (1), 114.
42. Scott-Burden, T., V.B. Schini, E. Elizondo, D.C. Jumquero and P.M. Vanhoutte, 1992, Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation, Circ. Res. 71, 1088.
43. Steiner, G., 1988, Diabetes and atherosclerosis: metabolic links, Drugs 36 (Suppl. 3), 22.